Effects of Rasagiline on Sleep Disturbances in PD: A Single Center, Randomized, Double-blind, Placebo run-in, Polysomnographic Clinical Phase IV Trial
Phase of Trial: Phase IV
Latest Information Update: 23 Jun 2016
At a glance
- Drugs Rasagiline (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms RaSPar
- 19 Sep 2015 Status changed from recruiting to completed, as reported by European Clinical Trials Database (EudraCT) record.
- 28 Jun 2014 Status changed from suspended to recruiting as reported by European Clinical Trials Database record.
- 19 Apr 2014 Status changed from recruiting to suspended, as per European Clinical Trials Database record.